Navigation Links
Barb Geiger, Former Executive Vice President of Clinical Development and Head of Global Oncology at Clinipace Inc., Joins NDA Partners as an Expert Consultant
Date:11/7/2018

NDA Partners Chairman Carl Peck, MD, announced today that Barb Geiger, a senior Clinical Operations professional with extensive experience in clinical trial management, including managing operations and trials focused on oncology and CNS development in the US, Australia, Latin America, Europe, and Asia, has joined the firm as an Expert Consultant.

Prior to joining NDA Partners, Ms. Geiger was the Executive Vice President of Clinical Development and Head of Global Oncology at Clinipace Inc., where she was responsible for providing direct oversight and strategy for the Clinical Operations Division in the US, Australia, and Latin America and for managing clinical operations interactions with the European division. She was the founder of Worldwide Clinical Research, Inc. and served as President until its acquisition by Clinipace Worldwide. She was formerly Director of Corporate Partnerships, Director of Business Development, Director of Operations, and Director of Project Management at PRA International. Early in her career, she served as the Assistant Director of Clinical Monitoring at ClinTrials, Inc. and a Clinical Scientist and Senior CRA at Marion Laboratories, Marion Merrell Dow, Inc.

According to Dr. Carl Peck, NDA Partners’ Chairman, “Ms. Geiger’s extensive experience in global clinical trial management, including managing operations and trials focused on oncology and CNS development, will be a valuable resource for our clients who are designing and conducting clinical trials worldwide. We are very pleased that she has joined NDA Partners’ team of Expert Consultants.”

Ms. Geiger earned a Bachelor of Science degree in nursing from the University of Kansas and was a graduate of Columbia University’s Senior Executive Program. She is a Registered Nurse having worked in the clinic in pediatric oncology and as an outpatient research coordinator. She is a member of the American Society of Clinical Oncology (ASCO) and the Drug Information Association (DIA).

About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle@ndapartners.com

Read the full story at https://www.prweb.com/releases/barb_geiger_former_executive_vice_president_of_clinical_development_and_head_of_global_oncology_at_clinipace_inc_joins_nda_partners_as_an_expert_consultant/prweb15894466.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Profil Institute Appoints Dan Bradbury, former Amylin Pharmaceutical CEO, to Board of Directors
2. DigitalPersona FingerJet Recognition Engine Top Performer in Recent MINEX Testing
3. Statement from the Secure Identity & Biometrics (SIBA) Chairman Paul Schuepp, Biometrics Expert, Former Animetrics CEO, on Providing Leadership for the Responsible Use of Biometrics in Commercial and Government Sectors
4. Chimpanzees raised as pets or performers suffer long-term effects on their behavior
5. C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer
6. Veridium Appoints Former HSBC Fintech Head James Stickland as New CEO
7. Former Anthem President Jimmy Lee Joins Fit4D’s Advisory Board
8. Five-Time World Champion Boxer Vinny Paz Shares Thoughts About Upcoming Movie, Bleed For This (Executive Produced by Martin Scorsese and Starring Miles Teller), Boxing, God and Whats Next
9. Five-Time World Champion Boxer Vinny Paz Shares Thoughts About Upcoming Movie, "Bleed For This" (Executive Produced by Martin Scorsese and Starring Miles Teller), Boxing, God and Whats Next
10. Genpact Executive Jeff Schultz Joins QStride As Vice President of National Business Development
11. Sandata Technologies Expands Leadership Team with Product Management Executive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2020)... Mass. (PRWEB) , ... June 24, 2020 , ... ... of cloud-based enterprise software and software-driven clinical data services that accelerate drug development, ... for low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This ...
(Date:6/23/2020)... , ... June 23, 2020 , ... In its June ... interview with Dr. James L. Sherley, M.D., Ph.D., founder and director of stem ... company announced on June 16 that starting July 5 it would begin ...
(Date:6/11/2020)... ... June 08, 2020 , ... Cryo-Cell International’s announcement comes on ... workers in the medical field. The face masks will be distributed nationwide to ... every day to provide healthcare to pregnant women. The delivery of masks is ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 30, 2020 , ... Flagship ... of a new clinical diagnostics immuno-oncology service, TissueInsight . TissueInsight provides ... “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists in ...
(Date:6/28/2020)... ... June 25, 2020 , ... With ... a vaccine or drug treatment. In an effort to better understand the cellular ... the world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 approved ...
(Date:6/28/2020)... SILVER SPRING, Md. (PRWEB) , ... June 26, ... ... the leading trade association representing security solutions providers, today announced its strong opposition ... . , The bill would impose a blanket ban on most federal use ...
(Date:6/23/2020)... , ... June 23, 2020 , ... ... in complex indoor environments, announced today that Derek Fournier has been appointed CEO ... Chairman of the Board, effective immediately. , “DeCurtis Corporation has been on ...
Breaking Biology Technology: